19 C
New York
Friday, June 9, 2023

Taking On Challenges And Growing? – HOOKIPA Pharma Inc. (HOOK)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for HOOKIPA Pharma Inc. (HOOK) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 1.35%, to $1.50. The HOOKIPA Pharma Inc. has recorded 38,134 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.

Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $1.48 and fluctuated between $1.6000 as its day high and $1.4200 as its day low. The current market capitalization of HOOKIPA Pharma Inc. is $78.10M. A total of 2.02 million shares were traded on the day, compared to an average of 726.79K shares.

Insider trades can also provide insight into a stock’s future direction. During the recent three months, HOOK has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for HOOK in the last 3 months, the mean price target is $4.44 with high estimates of $8.00 and low estimates of $0.50. In terms of 52-week highs and lows, HOOK has a high of $2.05 and a low of $0.68.

As of this writing, HOOK has an earnings estimate of -$0.25 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.3. The company reported an EPS of -$0.17 in the last quarter, which was 19.00% higher than expectations of -$0.21.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. HOOK’s latest balance sheet shows that the firm has $66.91M in Cash & Short Term Investments as of fiscal 2021. There were $10.62M in debt and $27.65M in liabilities at the time. Its Book Value Per Share was $1.87, while its Total Shareholder’s Equity was $89.59M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HOOK is Buy with a score of 4.00.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles